IOLCP
IOL Chemicals & Pharmaceuticals
Each stock's 10,000-path forecast, rendered as light.
IOL Chemicals & Pharmaceuticals (IOLCP) Stock Analysis & Case Study
Is IOLCP a good buy? The data-driven verdict.
IOL Chemicals & Pharmaceuticals (IOLCP) trades at ₹131,on the numbers it tread carefully, a Downstox Snapshot Score of 42/100.
On the numbers, IOL Chemicals & Pharmaceuticals (IOLCP) tread carefully, a Downstox Snapshot Score of 42/100, weighing premium at 26.3× earnings, ROE of 8.4%, a 60% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
IOLCP fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is IOLCP overvalued? IOLCP P/E vs its sector
IOLCP's P/E of 26.3× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 0.76% dividend yield is below the peer median of 1.65%.
IOLCP share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of IOLCP history (24%/yr drift, 46%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| IOLCP 2027 | ₹82 | ₹146 | ₹267 | +13% |
| IOLCP 2028 | ₹72 | ₹167 | ₹389 | +28% |
| IOLCP 2029 | ₹68 | ₹192 | ₹527 | +47% |
| IOLCP 2030 | ₹67 | ₹217 | ₹702 | +66% |
| IOLCP 2031 | ₹66 | ₹248 | ₹919 | +91% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability IOLCP goes up, or doubles?
The bull case for IOLCP
- A 10,000-path probability model puts a 60% chance the price is higher in a year, with a median target of ₹146 (+13%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹527.
The bear case & risks
- At 26.3× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.
- Return on equity is a soft 8.4%, capital efficiency trails higher-quality peers.
- High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹68.
IOLCP volatility & expected range, how bumpy is the ride?
Over the last 2.0 years IOLCP compounded at 24%/year with annualized volatility of 46%. That volatility implies a 1-year 80% range of ₹82–₹267, the honest backbone behind any single price target.
IOLCP price forecast, the full 60-month probability fan
IOLCP price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds IOLCP hits common targets within the simulated horizon?
Full multi-horizon detail on the IOLCP price target & forecast page.
IOLCP Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. IOLCP scores 4/9,mixed financial health.
IOLCP MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy IOLCP with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 37.5% | 2.7× |
| Groww | 37.6% | 2.7× |
| DhanCHEAPEST | 37.5% | 2.7× |
Compare every broker on the IOLCP MTF page.
IOLCP vs peers,sector comparison
About IOL Chemicals & Pharmaceuticals: sector, index & market-cap context
IOL Chemicals & Pharmaceuticals (IOLCP) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹3,837 Cr. See more Nifty 500 stocks.
How the IOLCP Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of IOL Chemicals & Pharmaceuticals's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
IOLCP analysis, FAQs
Is IOL Chemicals & Pharmaceuticals (IOLCP) a good buy?
On the numbers, IOL Chemicals & Pharmaceuticals (IOLCP) tread carefully, a Downstox Snapshot Score of 42/100, weighing premium at 26.3× earnings, ROE of 8.4%, a 60% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is IOLCP overvalued or undervalued?
IOLCP trades at 26.3× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the IOLCP share price target for 2031?
IOLCP's probability-weighted 2031 median target is ₹248, with an 80% range of ₹66–₹919 (10,000-path Monte-Carlo).
What is the probability IOLCP doubles in 5 years?
The modelled probability of IOLCP reaching ₹260 (2×) within 5 years is 48%.
What is the bull case for IOLCP?
A 10,000-path probability model puts a 60% chance the price is higher in a year, with a median target of ₹146 (+13%).
What are the risks in IOLCP?
At 26.3× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished. Return on equity is a soft 8.4%, capital efficiency trails higher-quality peers. High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.